A study to test BI 764198 in people with a type of kidney disease called focal segmental glomerulosclerosis.
Clinical Trial Grant
Administered By
Pediatrics, Nephrology
Awarded By
Boehringer Ingelheim Pharmaceuticals, Inc.
Start Date
July 5, 2022
End Date
May 1, 2024
Administered By
Pediatrics, Nephrology
Awarded By
Boehringer Ingelheim Pharmaceuticals, Inc.
Start Date
July 5, 2022
End Date
May 1, 2024